Jones Christy sold 2,811 shares of Beta Bionics, Inc. at $14.00 for −$39.4k on Jun 4, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Director
DIR
Filed Jun 5, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$39,354Shares × reported price
Shares traded
2,811Common Stock
Price per share
$14.00Reported price. Read footnotes for ranges.
% of reported position traded
9.3%This security and ownership context
Holdings after
27,400Direct
Trade date
Jun 4, 2026Sell
Filed
Jun 5, 2026, 6:05 PM ET1-day reporting delay
Accession
0002048467-26-000004Code S · Transaction 99840
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 30,211 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

BBNX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
BBNX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −28%1w ago −13%1d ago −10%
Returns since7d +4.6%30d +21%90d180d1y

Footnotes in full

F1: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on February 19, 2026.